Effectiveness of gentamicin for gonorrhoea treatment: systematic review and meta-analysis
Authors:
- 15 February 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 89 (1049) , 142-147
Abstract
Objectives The development of resistance to multiple antimicrobial agents has limited treatment options for gonorrhoea. The potential emergence of cephalosporin resistance in Neisseria gonorrhoeae and cephalosporin allergy in some patients make it necessary to evaluate the effectiveness of other available antimicrobial agents. Gentamicin is widely available in the USA and is used for gonorrhoea treatment in several countries. We conducted a systematic review of the medical literature to assess the effectiveness of gentamicin for treatment of uncomplicated urogenital gonococcal infections. Methods Two reviewers assessed relevant articles and independently selected studies that met prespecified selection criteria (including systematic enrolment and assignment to treatment and culture-confirmed diagnosis and outcome). Summary measures for selected studies were pooled using inverse variance-weighted averages with fixed effects. Heterogeneity was assessed using I2, which estimates proportion (0–100%) of variability attributable to heterogeneity between studies. Pooled percentage with negative follow-up culture was compared with Centers for Disease Control and Prevention (CDC) criteria for selection of recommended therapy (lower 95% CI of efficacy ≥95%). Results Twenty-nine potentially relevant studies were identified; three met inclusion criteria. Two studies used 240 mg intramuscular gentamicin and one used 280 mg. Percentages with negative culture after single-dose treatment were 90.7% (n=86), 91.4% (n=220) and 95.0% (n=40). Pooled percentage with negative culture after single-dose treatment was 91.5% (95% CI 88.1% to 94.0%, I2=0%). Conclusions Gentamicin does not meet current CDC criteria for recommended treatment of gonorrhoea. However, if cephalosporin resistance emerges, gentamicin may be a useful alternative agent. Evaluation of additional regimens, including combination therapy, is warranted.Keywords
This publication has 14 references indexed in Scilit:
- High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: NovelpenAMosaic Allele in a Successful International Clone Causes Treatment FailureAntimicrobial Agents and Chemotherapy, 2012
- Neisseria gonorrhoeae Antimicrobial Susceptibility in Lilongwe, Malawi, 2007Sexually Transmitted Diseases, 2010
- Update on the Management of Gonorrhea in Adults in the United StatesClinical Infectious Diseases, 2007
- Remarkable Increase in Central Japan in 2001-2002 of Neisseria gonorrhoeae Isolates with Decreased Susceptibility to Penicillin, Tetracycline, Oral Cephalosporins, and FluoroquinolonesAntimicrobial Agents and Chemotherapy, 2004
- Versatility of Aminoglycosides and Prospects for Their FutureClinical Microbiology Reviews, 2003
- Addition of Treatment for Trichomoniasis to Syndromic Management of Urethritis in Malawi:Sexually Transmitted Diseases, 2003
- Drugs of Choice for the Treatment of Uncomplicated Gonococcal InfectionsClinical Infectious Diseases, 1995
- Efficacy of Gentamicin and Kanamycin in the Treatment of Uncomplicated Gonococcal Urethritis in ZambiaSexually Transmitted Diseases, 1985
- Ototoxicity of Gentamicin in Man: A Survey and Controlled Analysis of Clinical Experience in the United StatesThe Journal of Infectious Diseases, 1971
- Gentamicin in Gonococcal Urethritis of Filipino Males: Dosage and ResponseThe Journal of Infectious Diseases, 1971